0000885590-13-000021.txt : 20130423
0000885590-13-000021.hdr.sgml : 20130423
20130423142349
ACCESSION NUMBER: 0000885590-13-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130420
FILED AS OF DATE: 20130423
DATE AS OF CHANGE: 20130423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kornwasser Laizer
CENTRAL INDEX KEY: 0001387813
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 13776068
MAIL ADDRESS:
STREET 1: 100 PARSONS POND DRIVE
CITY: FRANKLIN LAKES
STATE: NJ
ZIP: 07417
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-04-20
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001387813
Kornwasser Laizer
4787 LEVY ROAD
MONTREAL
A8
H4R 2P9
QUEBEC, CANADA
0
1
0
0
EVP, Company Group Chairman
Common Stock, no par value
2013-04-20
4
A
0
2000
0
A
4000
D
Represents Restricted Share Units received under an Employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
1/3 of the Matching RSUs will vest each on the first, second and third anniversary of the date of grant subject to continued employment and retention of the corresponding purchased shares.
This number represents common shares purchased by the officer, as well as other outstanding equity awards that were previously reported in Table 1.
by: Nicholas Zanoni for Laizer Kornwasser
2013-04-23